U.S. Large Molecule Bioanalytical Testing Services Market Size & Outlook

The large molecule bioanalytical testing services market in the United States is expected to reach a projected revenue of US$ 1,551.2 million by 2030. A compound annual growth rate of 9.4% is expected of the United States large molecule bioanalytical testing services market from 2022 to 2030.

Revenue, 2021 (US$M)
$692.5
Forecast, 2030 (US$M)
$1,551.2
CAGR, 2022 - 2030
9.4%
Report Coverage
U.S.

U.S. large molecule bioanalytical testing services market, 2018-2030 (US$M)

U.S.

Related Markets

U.S. large molecule bioanalytical testing services market highlights

  • The U.S. large molecule bioanalytical testing services market generated a revenue of USD 692.5 million in 2021 and is expected to reach USD 1,551.2 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 9.4% from 2022 to 2030.
  • In terms of segment, clinical was the largest revenue generating phase in 2021.
  • Preclinical is the most lucrative phase segment registering the fastest growth during the forecast period.


Large molecule bioanalytical testing services market data book summary

Market revenue in 2021USD 692.5 million
Market revenue in 2030USD 1,551.2 million
Growth rate9.4% (CAGR from 2021 to 2030)
Largest segmentClinical
Fastest growing segmentPreclinical
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPreclinical, Clinical
Key market players worldwideLabcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc


Other key industry trends

  • In terms of revenue, U.S. accounted for 43.4% of the global large molecule bioanalytical testing services market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. large molecule bioanalytical testing services market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 1,551.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Large Molecule Bioanalytical Testing Services Market Scope

Large molecule bioanalytical testing services market segmentation & scope
With Antibody
Without Antibody (ELISA Based Assay)
Clinical
Pharmacokinetics
ADA
Others
ADME
PD
Bioavailability
Bioequivalence
Other Tests
Oncology
Infectious Diseases
Cardiology
Neurology
Others
CROs & CMOs
Sponsor Organizations
Others (Academic institute, etc.)
CROs & CMOs
Sponsor Organizations
Others (Academic institute, etc.)

Large Molecule Bioanalytical Testing Services Market Companies

Name Profile # Employees HQ Website

U.S. large molecule bioanalytical testing services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 66.14% in 2021. Horizon Databook has segmented the U.S. large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.


This growth can be attributed to rapid increase in development of biologics to meet the growing demand for efficient healthcare in the country and strong R&D & promotion of new therapies. High healthcare expenditure in the country will also augment market growth.

Growing investment in pharmaceutical R&D coupled with rising number of clinical trials will also boost the U.S. large molecule bioanalytical testing market. For instance, the U.S. conducted 134,516 clinical trials between 1999 and 2019, as registered on WHO’s International Clinical Trials Registry Platform (ICTRP).

Robust product pipeline in the pharmaceutical and biopharmaceutical industry will also augment market growth for large molecule bioanalytical testing in the country.

Reasons to subscribe to U.S. large molecule bioanalytical testing services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. large molecule bioanalytical testing services market databook

  • Our clientele includes a mix of large molecule bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. large molecule bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into U.S. large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. large molecule bioanalytical testing services market size, by phase, 2018-2030 (US$M)

U.S. Large Molecule Bioanalytical Testing Services Market Outlook Share, 2021 & 2030 (US$M)

U.S. large molecule bioanalytical testing services market size, by phase, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more